Bayesian Capital Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-8,100	Closed	-$1.24M	–	725
2021 Q1	$1.24M	Buy	8,100 +4,200	+108%	+$650K	0.29%	92
2020 Q4	$609K	Buy	+3,900	New	+$501K	0.16%	183
2020 Q3	–	Sell	-3,009	Closed	-$338K	–	760
2020 Q2	$338K	Sell	3,009 -8,637	-74%	-$917K	0.07%	324
2020 Q1	$1.05M	Buy	11,646 +8,146	+233%	+$799K	0.23%	122
2019 Q4	$379K	Sell	3,500 -3,577	-51%	-$383K	0.06%	364
2019 Q3	$693K	Buy	+7,077	New	+$798K	0.13%	214
2019 Q1	–	Sell	-5,611	Closed	-$546K	–	823
2018 Q4	$546K	Buy	+5,611	New	+$663K	0.11%	261
2017 Q4	–	Sell	-9,300	Closed	-$1.3M	–	779
2017 Q3	$1.3M	Buy	+9,300	New	+$1.26M	0.31%	96
2017 Q1	–	Sell	-6,282	Closed	-$769K	–	765
2016 Q4	$769K	Buy	6,282 +1,082	+21%	+$132K	0.19%	198
2016 Q3	$637K	Buy	+5,200	New	+$669K	0.42%	75